Literature DB >> 7673967

Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.

J E Nielsen1, L N Jensen, K Krabbe.   

Abstract

Hereditary haemochromatosis is characterised by excessive parenchymal iron deposition, particularly in the liver. Usually hereditary haemochromatosis is not associated with neurological symptoms and iron deposition in the brain has not previously been described as a pathological phenomenon. A patient is reported with hereditary haemochromatosis and a syndrome of dementia, dysarthria, a slowly progressive gait disturbance, imbalance, muscle weakness, rigidity, bradykinesia, tremor, ataxia, and dyssynergia. The findings on MRI of a large signal decrease in the basal ganglia, consistent with excessive iron accumulation, indicate a causal relation to the symptoms. Although the neurological symptoms did not improve in our patient, hereditary haemochromatosis should be considered in the differential diagnosis of parkinsonian syndromes, because complications of iron induced organ injury may be prevented by phlebotomy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673967      PMCID: PMC486041          DOI: 10.1136/jnnp.59.3.318

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Authors:  M B Youdim; D Ben-Shachar; P Riederer
Journal:  Acta Neurol Scand Suppl       Date:  1989

2.  Magnetic resonance imaging and extrapyramidal movement disorders.

Authors:  B P Drayer
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

3.  A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.

Authors:  M Simon; L Le Mignon; R Fauchet; J Yaouanq; V David; G Edan; M Bourel
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

Review 4.  Hereditary haemochromatosis.

Authors:  C Q Edwards; M M Dadone; M H Skolnick; J P Kushner
Journal:  Clin Haematol       Date:  1982-06

5.  An HLA study in 74 Danish haemochromatosis patients and in 21 of their families.

Authors:  N Milman; N Graudal; L S Nielsen; K Fenger
Journal:  Clin Genet       Date:  1992-01       Impact factor: 4.438

Review 6.  Idiopathic hemochromatosis, an interim report.

Authors:  M S Milder; J D Cook; S Stray; C A Finch
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

7.  Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity.

Authors:  D Eidelberg; A Sotrel; C Joachim; D Selkoe; A Forman; W W Pendlebury; D P Perl
Journal:  Brain       Date:  1987-08       Impact factor: 13.501

8.  Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs.

Authors:  H R Jones; E T Hedley-Whyte
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration.

Authors:  H Miyajima; Y Nishimura; K Mizoguchi; M Sakamoto; T Shimizu; N Honda
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

10.  Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.

Authors:  J Jankovic; J B Kirkpatrick; K A Blomquist; P J Langlais; E D Bird
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

View more
  37 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 2.  Hereditary caeruloplasmin deficiency: clinicopathological study of a patient.

Authors:  T Kawanami; T Kato; M Daimon; M Tominaga; H Sasaki; K Maeda; S Arai; Y Shikama; T Katagiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

3.  Hereditary hemochromatosis and movement disorders: the still controversial relationship. Response to Russo et al. in J Neurol (2004) 251:849-852.

Authors:  G Demarquay; S Thobois; P Latour; Emmanuel Broussolle
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

4.  Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association?

Authors:  M P Rutgers; A Pielen; M Gille
Journal:  J Neurol       Date:  2007-04-21       Impact factor: 4.849

5.  Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Authors:  Alfonso Fasano; Anna Rita Bentivoglio; Cesare Colosimo
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

6.  A parkinsonian movement disorder with brain iron deposition and a haemochromatosis mutation.

Authors:  Stefan Williams; Maruthi Ravi Vinjam; Azzam Ismail; Ahamad Hassan
Journal:  J Neurol       Date:  2013-06-23       Impact factor: 4.849

Review 7.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

Review 8.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

Review 9.  Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review.

Authors:  Noemi Russo; Mark Edwards; Thomasin Andrews; Michael O'Brien; Kailash P Bhatia
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.